Conclusions
MYOPIA, SIDE EFFECTS
In conclusion, low-dose atropine eye drops seem to exhibit similar effectiveness in Danish children to that reported in Asian children following twelve months of treatment, but the effect was not significant following multiple comparisons adjustment. Low-dose atropine eye drops are safe, with a moderate amount of side effects, which primarily occurred in the 0.1% loading dose group, and which were promptly reduced following switch-over to the 0.01% dose. Low-dose atropine eye drops may have a small, but clinically relevant effect at reducing myopia progression in Danish children. Side effects related to pupil-dilation should not be a major concern when prescribing 0.01% low-dose atropine eye drops for Caucasian children.